STOCK TITAN

[SCHEDULE 13D] Forian Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D
Rhea-AI Filing Summary

Consortium delivers non-binding going-private proposal for Forian Inc. A group of related investors led by Max C. Wygod and other reporting persons delivered an Offer Letter to Forian's board proposing to acquire all outstanding common stock not owned by the Consortium in a going-private transaction. The members executed a Consortium Agreement dated August 25, 2025, to govern cooperation; copies are filed as Exhibits 99.1 and 99.2. The filing reports individual beneficial ownership stakes, including Max C. Wygod (14.7%), Anthony Vuolo (12.9%), and other consortium-affiliated trusts and persons, calculated on 31,112,312 outstanding shares. The Offer Letter is non-binding, any transaction would require special committee approval and definitive documentation, financing sources are not finalized, and consummation would terminate Forian's Nasdaq registration if completed.

Il Consorzio presenta una proposta non vincolante per la privatizzazione di Forian Inc. Un gruppo di investitori collegati, guidato da Max C. Wygod e da altri soggetti segnalanti, ha consegnato al consiglio di amministrazione di Forian una Lettera di Offerta proponendo l'acquisizione di tutte le azioni ordinarie in circolazione non già detenute dal Consorzio, nell'ambito di un'operazione di going-private. I membri hanno stipulato un Accordo di Consorzio in data 25 agosto 2025 per disciplinare la collaborazione; copie sono allegate come Exhibit 99.1 e 99.2. La comunicazione riporta le partecipazioni azionarie in capo ai singoli soggetti, inclusi Max C. Wygod (14,7%), Anthony Vuolo (12,9%) e altri trust e persone affiliati al consorzio, calcolate su un totale di 31.112.312 azioni in circolazione. La Lettera di Offerta è non vincolante: qualsiasi operazione richiederebbe l'approvazione di un comitato speciale e la sottoscrizione di documenti definitivi, le fonti di finanziamento non sono state ancora definite e, in caso di completamento, l'operazione comporterebbe la cancellazione della registrazione di Forian presso il Nasdaq.

El Consorcio presenta una propuesta no vinculante para privatizar Forian Inc. Un grupo de inversores relacionados, encabezado por Max C. Wygod y otras personas informantes, entregó una Carta de Oferta al consejo de administración de Forian proponiendo adquirir todas las acciones ordinarias en circulación que no posea el Consorcio, en una operación de going-private. Los miembros suscribieron un Acuerdo de Consorcio con fecha 25 de agosto de 2025 para regular la cooperación; se adjuntan copias como Exhibits 99.1 y 99.2. La presentación informa las participaciones beneficiarias individuales, incluyendo a Max C. Wygod (14,7%), Anthony Vuolo (12,9%) y otros fideicomisos y personas vinculadas al consorcio, calculadas sobre 31.112.312 acciones en circulación. La Carta de Oferta no es vinculante; cualquier transacción requeriría la aprobación de un comité especial y documentación definitiva, las fuentes de financiación no están finalizadas y, de concretarse, la operación daría lugar a la baja de la inscripción de Forian en el Nasdaq.

컨소시엄, Forian Inc.의 비공개화(going-private) 비구속 제안 제출 맥스 C. 와이고드(Max C. Wygod)와 기타 신고인들이 주도하는 관련 투자자 그룹이 Forian 이사회에 제안서를 제출하여 컨소시엄이 보유하지 않은 모든 발행 보통주를 인수하는 비공개화 거래를 제안했습니다. 구성원들은 협력 규정을 위해 2025년 8월 25일자 컨소시엄 계약을 체결했으며, 사본은 Exhibit 99.1 및 99.2로 제출되어 있습니다. 제출서에는 맥스 C. 와이고드(14.7%), 앤서니 부올로(12.9%) 및 기타 컨소시엄 관련 신탁과 개인을 포함한 개인별 실질 보유 지분이 총 31,112,312주를 기준으로 보고되어 있습니다. 제안서는 비구속적이며, 어떤 거래도 특별위원회 승인과 확정 서류가 필요하고, 자금 조달원은 확정되지 않았으며, 거래가 완료되면 Forian의 나스닥 등록이 취소됩니다.

Le consortium présente une proposition non contraignante de retrait de cote pour Forian Inc. Un groupe d'investisseurs liés, dirigé par Max C. Wygod et d'autres personnes déclarantes, a remis une lettre d'offre au conseil d'administration de Forian proposant d'acquérir toutes les actions ordinaires en circulation qui ne sont pas détenues par le consortium, dans le cadre d'une opération de going-private. Les membres ont signé un accord de consortium en date du 25 août 2025 pour régir leur coopération ; des copies sont déposées en tant qu'Exhibits 99.1 et 99.2. Le dépôt signale les participations bénéficiaires individuelles, y compris Max C. Wygod (14,7%), Anthony Vuolo (12,9%) et d'autres trusts et personnes affiliés au consortium, calculées sur 31 112 312 actions en circulation. La lettre d'offre est non contraignante : toute opération requerrait l'approbation d'un comité spécial et la documentation définitive, les sources de financement ne sont pas finalisées et, si l'opération était menée à terme, l'inscription de Forian au Nasdaq serait radiée.

Konsortium reicht unverbindliches Going-Private-Angebot für Forian Inc. ein Eine Gruppe miteinander verbundener Investoren unter Führung von Max C. Wygod und weiteren meldepflichtigen Personen hat dem Aufsichtsrat von Forian ein Angebotsschreiben übermittelt, in dem der Erwerb aller ausstehenden Stammaktien vorgeschlagen wird, die nicht vom Konsortium gehalten werden, im Rahmen einer Going-Private-Transaktion. Die Mitglieder haben am 25. August 2025 eine Konsortialvereinbarung zur Regelung der Zusammenarbeit unterzeichnet; Kopien sind als Exhibits 99.1 und 99.2 eingereicht. Die Meldung nennt die individuellen wirtschaftlichen Beteiligungen, darunter Max C. Wygod (14,7%), Anthony Vuolo (12,9%) sowie weitere konsortialnahe Trusts und Personen, berechnet auf 31.112.312 ausstehende Aktien. Das Angebotsschreiben ist unverbindlich: Jede Transaktion würde die Zustimmung eines Sonderausschusses und endgültige Dokumentation erfordern, Finanzierungsquellen sind noch nicht festgelegt, und im Falle eines Vollzugs würde die Registrierung von Forian an der Nasdaq beendet werden.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: A sizable investor consortium submitted a non-binding going-private proposal and formed a consortium agreement; outcome depends on negotiations and financing.

The Schedule 13D discloses coordinated action by multiple related investors and funds to pursue a going-private offer for Forian Inc. The document is explicit that the Offer Letter is non-binding and conditional on special committee approval and definitive agreements. Reported beneficial holdings are material relative to the 31,112,312-share base used for calculations, with several reporting persons holding double-digit percentages individually or via trusts. Key near-term variables are negotiation progress, definitive documentation, and finalized financing; none are finalized in this filing.

TL;DR: Formation of a formal consortium and a delivered Offer Letter signal a coordinated acquisition effort that could materially alter shareholder liquidity if completed.

The filing confirms a signed Consortium Agreement and a delivered Offer Letter (Exhibits 99.1 and 99.2), both core M&A milestones for a negotiated transaction. Significant aggregate holdings among consortium members are disclosed and could facilitate a negotiated outcome, but the absence of definitive terms and finalized financing keeps the proposal conditional. If definitive agreements follow, the transaction contemplates delisting and termination of public registration, a fundamental change to capital market access for holders.

Il Consorzio presenta una proposta non vincolante per la privatizzazione di Forian Inc. Un gruppo di investitori collegati, guidato da Max C. Wygod e da altri soggetti segnalanti, ha consegnato al consiglio di amministrazione di Forian una Lettera di Offerta proponendo l'acquisizione di tutte le azioni ordinarie in circolazione non già detenute dal Consorzio, nell'ambito di un'operazione di going-private. I membri hanno stipulato un Accordo di Consorzio in data 25 agosto 2025 per disciplinare la collaborazione; copie sono allegate come Exhibit 99.1 e 99.2. La comunicazione riporta le partecipazioni azionarie in capo ai singoli soggetti, inclusi Max C. Wygod (14,7%), Anthony Vuolo (12,9%) e altri trust e persone affiliati al consorzio, calcolate su un totale di 31.112.312 azioni in circolazione. La Lettera di Offerta è non vincolante: qualsiasi operazione richiederebbe l'approvazione di un comitato speciale e la sottoscrizione di documenti definitivi, le fonti di finanziamento non sono state ancora definite e, in caso di completamento, l'operazione comporterebbe la cancellazione della registrazione di Forian presso il Nasdaq.

El Consorcio presenta una propuesta no vinculante para privatizar Forian Inc. Un grupo de inversores relacionados, encabezado por Max C. Wygod y otras personas informantes, entregó una Carta de Oferta al consejo de administración de Forian proponiendo adquirir todas las acciones ordinarias en circulación que no posea el Consorcio, en una operación de going-private. Los miembros suscribieron un Acuerdo de Consorcio con fecha 25 de agosto de 2025 para regular la cooperación; se adjuntan copias como Exhibits 99.1 y 99.2. La presentación informa las participaciones beneficiarias individuales, incluyendo a Max C. Wygod (14,7%), Anthony Vuolo (12,9%) y otros fideicomisos y personas vinculadas al consorcio, calculadas sobre 31.112.312 acciones en circulación. La Carta de Oferta no es vinculante; cualquier transacción requeriría la aprobación de un comité especial y documentación definitiva, las fuentes de financiación no están finalizadas y, de concretarse, la operación daría lugar a la baja de la inscripción de Forian en el Nasdaq.

컨소시엄, Forian Inc.의 비공개화(going-private) 비구속 제안 제출 맥스 C. 와이고드(Max C. Wygod)와 기타 신고인들이 주도하는 관련 투자자 그룹이 Forian 이사회에 제안서를 제출하여 컨소시엄이 보유하지 않은 모든 발행 보통주를 인수하는 비공개화 거래를 제안했습니다. 구성원들은 협력 규정을 위해 2025년 8월 25일자 컨소시엄 계약을 체결했으며, 사본은 Exhibit 99.1 및 99.2로 제출되어 있습니다. 제출서에는 맥스 C. 와이고드(14.7%), 앤서니 부올로(12.9%) 및 기타 컨소시엄 관련 신탁과 개인을 포함한 개인별 실질 보유 지분이 총 31,112,312주를 기준으로 보고되어 있습니다. 제안서는 비구속적이며, 어떤 거래도 특별위원회 승인과 확정 서류가 필요하고, 자금 조달원은 확정되지 않았으며, 거래가 완료되면 Forian의 나스닥 등록이 취소됩니다.

Le consortium présente une proposition non contraignante de retrait de cote pour Forian Inc. Un groupe d'investisseurs liés, dirigé par Max C. Wygod et d'autres personnes déclarantes, a remis une lettre d'offre au conseil d'administration de Forian proposant d'acquérir toutes les actions ordinaires en circulation qui ne sont pas détenues par le consortium, dans le cadre d'une opération de going-private. Les membres ont signé un accord de consortium en date du 25 août 2025 pour régir leur coopération ; des copies sont déposées en tant qu'Exhibits 99.1 et 99.2. Le dépôt signale les participations bénéficiaires individuelles, y compris Max C. Wygod (14,7%), Anthony Vuolo (12,9%) et d'autres trusts et personnes affiliés au consortium, calculées sur 31 112 312 actions en circulation. La lettre d'offre est non contraignante : toute opération requerrait l'approbation d'un comité spécial et la documentation définitive, les sources de financement ne sont pas finalisées et, si l'opération était menée à terme, l'inscription de Forian au Nasdaq serait radiée.

Konsortium reicht unverbindliches Going-Private-Angebot für Forian Inc. ein Eine Gruppe miteinander verbundener Investoren unter Führung von Max C. Wygod und weiteren meldepflichtigen Personen hat dem Aufsichtsrat von Forian ein Angebotsschreiben übermittelt, in dem der Erwerb aller ausstehenden Stammaktien vorgeschlagen wird, die nicht vom Konsortium gehalten werden, im Rahmen einer Going-Private-Transaktion. Die Mitglieder haben am 25. August 2025 eine Konsortialvereinbarung zur Regelung der Zusammenarbeit unterzeichnet; Kopien sind als Exhibits 99.1 und 99.2 eingereicht. Die Meldung nennt die individuellen wirtschaftlichen Beteiligungen, darunter Max C. Wygod (14,7%), Anthony Vuolo (12,9%) sowie weitere konsortialnahe Trusts und Personen, berechnet auf 31.112.312 ausstehende Aktien. Das Angebotsschreiben ist unverbindlich: Jede Transaktion würde die Zustimmung eines Sonderausschusses und endgültige Dokumentation erfordern, Finanzierungsquellen sind noch nicht festgelegt, und im Falle eines Vollzugs würde die Registrierung von Forian an der Nasdaq beendet werden.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEMS 7, 9 Includes (i) 3,645,399 shares held by the Max Wygod Family Dynasty Trust of which Mr. Vuolo is trustee and has sole investment and dispositive power; Mr. Vuolo disclaims beneficial ownership of these shares; and 370,396 shares held directly by Mr. Vuolo. ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEMS 8, 10, 11 Mr. Usdan disclaims beneficial ownership of these shares. ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEMS 8, 10 Ms. Dublin disclaims beneficial ownership of these shares. ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEMS 8, 10 Mr. Spaniel disclaims beneficial ownership of these shares. ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEMS 8, 10, 11 Includes (i) 525,000 shares held jointly by Mr. Berg and his spouse, Rachel Berg, (ii) 237,578 shares held by Rachel Berg GST Exempt 2012 Trust, of which Mr. Berg is trustee, (iii) 597,000 shares held directly by Mr. Berg, (iv) 52,000 shares held by Rachel Berg, over which Mr. Berg has investment authority, (v) 32,300 shares held by Eric Berg, over which Mr. Berg has investment authority, (vi) 30,300 shares held by Adam Berg, over which Mr. Berg has investment authority, (vii) 36,700 shares held by Emma Berg, over which Mr. Berg has investment authority, and (viii) 30,000 shares held by Alexander Berg, over which Mr. Berg has investment authority. ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
ITEMS 8, 10 Includes 80,154.00 shares held by Mr. Glick in joint tenancy with his spouse, Sharon Glick. ITEM 13 Calculated based on 31,112,312 shares of common stock of the Issuer outstanding as of August 13, 2025, as reported on the Issuer's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025.


SCHEDULE 13D


2025 Acquisition Corp
Signature:/s/ Max C. Wygod
Name/Title:Max C. Wygod
Date:08/25/2025
Wygod Max C
Signature:/s/ Max C. Wygod
Name/Title:Max C. Wygod
Date:08/25/2025
Emily Bushnell
Signature:/s/ Emily Bushnell
Name/Title:Emily Bushnell
Date:08/25/2025
ADMINISTRATIVE TRUST U/ WYGOD FAMILY RV
Signature:/s/ Max C. Wygod
Name/Title:Max C. Wygod, Co-Trustee
Date:08/25/2025
Signature:/s/ Emily Bushnell
Name/Title:Emily Bushnell, Co-Trustee
Date:08/25/2025
Anthony Vuolo
Signature:/s/ Anthony Vuolo
Name/Title:Anthony Vuolo
Date:08/25/2025
WYGOD FAMILY REV LT U/T/A
Signature:/s/ Emily Bushnell
Name/Title:Emily Bushnell, Co-Trustee
Date:08/25/2025
Signature:/s/ Max C. Wygod
Name/Title:Max C. Wygod, Co-Trustee
Date:08/25/2025
MAX WYGOD FAMILY DYNASTY TRUST
Signature:/s/ Anthony Vuolo
Name/Title:Anthony Vuolo, Trustee
Date:08/25/2025
FEINBERG LARRY N
Signature:/s/ Larry N. Feinberg
Name/Title:Larry N. Feinberg
Date:08/25/2025
ORACLE PARTNERS, L.P.
Signature:/s/ Larry N. Feinberg
Name/Title:Larry N. Feinberg, Managing Member
Date:08/25/2025
ORACLE INSTITUTIONAL PARTNERS, L.P.
Signature:/s/ Larry N. Feinberg
Name/Title:Larry N. Feinberg, Managing Member
Date:08/25/2025
ORACLE TEN FUND, L.P.
Signature:/s/ Larry N. Feinberg
Name/Title:Larry N. Feinberg, Managing Member
Date:08/25/2025
ORACLE INVESTMENT MANAGEMENT, INC. EMPLOYEES' RETIREMENT PLAN
Signature:/s/ Larry N. Feinberg
Name/Title:Larry N. Feinberg, Trustee
Date:08/25/2025
THE FEINBERG FAMILY FOUNDATION
Signature:/s/ Larry N. Feinberg
Name/Title:Larry N. Feinberg, Trustee
Date:08/25/2025
ORACLE ASSOCIATES, LLC
Signature:/s/ Larry N. Feinberg
Name/Title:Larry N. Feinberg, Managing Member
Date:08/25/2025
ORACLE INVESTMENT MANAGEMENT, INC.
Signature:/s/ Larry N. Feinberg
Name/Title:Larry N. Feinberg, President
Date:08/25/2025
FEINBERG CHILDREN'S TRUST
Signature:/s/ Adam Usdan
Name/Title:Adam Usdan, Trustee
Date:08/25/2025
USDAN ADAM
Signature:/s/ Adam Usdan
Name/Title:Adam Usdan
Date:08/25/2025
Adam H. Dublin
Signature:/s/ Adam H. Dublin
Name/Title:Adam H. Dublin
Date:08/25/2025
ADAM H. DUBLIN 2019 FAMILY TRUST
Signature:/s/ Edward F. Spaniel, Jr.
Name/Title:Edward F. Spaniel, Jr., Co-Trustee
Date:08/25/2025
Phyllis Dublin
Signature:/s/ Phyllis Dublin
Name/Title:Phyllis Dublin
Date:08/25/2025
Edward F. Spaniel, Jr.
Signature:/s/ Edward F. Spaniel, Jr.
Name/Title:Edward F. Spaniel, Jr.
Date:08/25/2025
Carl Berg
Signature:/s/ Carl Berg
Name/Title:Carl Berg
Date:08/25/2025
MARBLE LANE PARTNERS I, LLC
Signature:/s/ David Mehlman
Name/Title:David Mehlman, Managing Member
Date:08/25/2025
Michael Sawyer
Signature:/s/ Michael Sawyer
Name/Title:Michael Sawyer
Date:08/25/2025
NELL AND JANE CAMERON 2006 TRUST
Signature:/s/ Keri Cameron
Name/Title:Keri Cameron, Trustee
Date:08/25/2025
Shahir Kassam-Adams
Signature:/s/ Shahir Kassam-Adams
Name/Title:Shahir Kassam-Adams
Date:08/25/2025
360 Ventures, LLC
Signature:/s/ Shahir Kassam-Adams
Name/Title:Shahir Kassam-Adams, General Manager
Date:08/25/2025
Charles Mele
Signature:/s/ Charles Mele
Name/Title:Charles Mele
Date:08/25/2025
Michael Glick
Signature:/s/ Michael Glick
Name/Title:Michael Glick
Date:08/25/2025

FAQ

What did the Schedule 13D filed for Forian Inc. (FORA) disclose?

The filing discloses that a consortium of investors delivered a non-binding Offer Letter proposing a going-private acquisition and executed a Consortium Agreement dated August 25, 2025 (Exhibits 99.1 and 99.2).

Who are the principal reporting persons in the consortium for FORA?

Reporting persons include Max C. Wygod, Anthony Vuolo, Emily Bushnell, Larry N. Feinberg and related entities, various trusts and partners as listed in Item 2.

How much of Forian's stock do consortium members report owning?

Percentages are calculated on 31,112,312 outstanding shares. Individual disclosed stakes include Max C. Wygod 14.7%, Anthony Vuolo 12.9%, and others as shown on the cover pages.

Is the proposed transaction binding or finalized?

No. The Offer Letter is explicitly described as non-binding, and any transaction would be conditioned on definitive agreements, special committee approval, and finalized financing.

What would happen to Forian's public listing if the transaction is completed?

If the Proposed Transaction is consummated, the filing states the Common Stock will no longer be traded on Nasdaq and registration under Section 12 is expected to be terminated.

Are the sources of funds for the proposed transaction determined?

No. The filing states financing is expected to be funded by a combination of personal resources, third-party financing and the Issuer's net cash, but specific amounts, sources and terms have not been finalized.
Forian Inc

NASDAQ:FORA

FORA Rankings

FORA Latest News

FORA Latest SEC Filings

FORA Stock Data

59.74M
14.96M
58.17%
13.59%
0.26%
Health Information Services
Services-computer Processing & Data Preparation
Link
United States
NEWTOWN